Medical impact of genetic alterations like germline DDX41 mutations in MDS/small-blast rely AML individuals addressed with azacitidine-primarily based regimens Marie Sébert While acute leukemia should be taken care of immediately, chronic kinds are occasionally monitored for a while ahead of treatment to make sure maximum performance of therapy. Serious leukemia https://directivepublications.org/journal-of-leukemia-research/